Assessing long-term survival benefits of immune checkpoint inhibitors using the net survival benefit.

Specific PHGKB|Cancer|PHGKB

Melanoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Mar 07, 2019

---

• Assessing long-term survival benefits of immune checkpoint inhibitors using the net survival benefit.  
  Péron Julien et al. Journal of the National Cancer Institute 2019 Mar
• Implementing TMB measurement in clinical practice: considerations on assay requirements.  
  Büttner Reinhard et al. ESMO open 2019 4(1) e000442
• Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control.  
  Parsons Bridget G et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 Feb
• Familial Melanoma: Diagnostic and Management Implications.  
  Rossi Mariarita et al. Dermatology practical & conceptual 2019 Jan 9(1) 10-16
• A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma.  
  Wu Yelena P et al. Patient education and counseling 2018 101(3) 452-459
• Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.  
  Bowen Deborah J et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 Feb
• Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.  
  Taylor Nicholas J et al. Journal of the American Academy of Dermatology 2019 Feb
• Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.  
  Ohmoto Akihiro et al. International journal of molecular sciences 2019 Jan 20(3)
• BRAF mutation testing in melanoma: results from a German observational multicenter study.  
  Hartmann Arndt et al. Virchows Archiv : an international journal of pathology 2019 Jan 474(1) 71-78
• Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.  
  Hyams David M et al. Journal of surgical oncology 2019 Jan 119(2) 175-186
• The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.  
  Armengot-Carbó Miquel et al. Journal of the American Academy of Dermatology 2018 78(5) 920-926.e4
• Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.  
  Fenton G L et al. The British journal of dermatology 2018 Dec
• Current Approaches to Pancreatic Cancer Screening.  
  Chhoda Ankit et al. The American journal of pathology 2019 Jan 189(1) 22-35
• An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile.  
  Li Yang et al. Journal of cellular biochemistry 2018 Dec
• Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine.  
  Tarhini Ahmad et al. Cancer treatment reviews 2018 Dec 718-18